HANDOK Inc.

₩8,280As of Sun 8 Nov 2026, 12:00 UTC
KRX:002390Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (8.25%)
Div yield 2.42%
ROE (3.65%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.16
PE TTM —
TSR TTM (26.11%)
Mkt cap ₩107.6B
ROIC 1.34%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩9,208
11.21%
(90.06%)
Hold 10|0|12|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
105.90
112.95
112.34
120.79
24.43%
21.08%
15.07%
18.01%
Revenue₩B
4.646
4.889
4.975
5.010
(1.49%)
3.52%
5.27%
7.33%
Peers (US$79.31M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.399
(0.824)
(0.608)
EBIT/Intx
0.977
1.022
0.780
Own earn%
62.30
(127.43)
(98.56)
Sh yield%
30.69
25.12
27.85
Owners
Insiders/Inst%
4.04
62.19
Short interest%
5.40
SBC / revenue%
2.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
7–15
$1 testx
—
Incr. ROIC%
3